Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein
- PMID: 7509433
- DOI: 10.1016/s0140-6736(94)92639-5
Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein
Abstract
Oxidised low-density lipoprotein (Ox-LDL) has been associated with arterial foam-cell formation, and autoantibodies to Ox-LDL are present in human serum. Lipid peroxidation is enhanced in pre-eclampsia. We assessed whether the titre of IgG autoantibody to an epitope of Ox-LDL, malondialdehyde-conjugated low-density lipoprotein (MDA-LDL), was increased in the sera of pre-eclamptic patients. 16 such patients had significantly higher mean titres of autoantibodies to MDA-LDL than healthy pregnant women (p = 0.028). In a multiple regression model, pre-eclamptic patients still had a significantly higher mean titre (p = 0.048). Enhanced lipid peroxidation may be involved in the foam-cell formation of decidua and in the pathogenesis of pre-eclampsia.
Comment in
-
Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary heart disease.Lancet. 1994 Jun 18;343(8912):1570. doi: 10.1016/s0140-6736(94)92971-8. Lancet. 1994. PMID: 7911891 No abstract available.
Similar articles
-
Antibodies against copper-oxidised and malondialdehyde-modified low density lipoproteins in pre-eclampsia pregnancies.Br J Obstet Gynaecol. 1998 Oct;105(10):1113-7. doi: 10.1111/j.1471-0528.1998.tb09945.x. Br J Obstet Gynaecol. 1998. PMID: 9800936 Clinical Trial.
-
Antibodies to oxidised low-density lipoproteins and cardiolipin in pre-eclampsia and eclampsia.J Obstet Gynaecol. 2002 Mar;22(2):123-6. doi: 10.1080/01443610120113247. J Obstet Gynaecol. 2002. PMID: 12521691
-
Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary heart disease.Lancet. 1994 Jun 18;343(8912):1570. doi: 10.1016/s0140-6736(94)92971-8. Lancet. 1994. PMID: 7911891 No abstract available.
-
Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.G Ital Cardiol. 1997 Dec;27(12):1302-14. G Ital Cardiol. 1997. PMID: 9470066 Review.
-
Immunological responses to oxidized LDL.Free Radic Biol Med. 2000 Jun 15;28(12):1771-9. doi: 10.1016/s0891-5849(00)00333-6. Free Radic Biol Med. 2000. PMID: 10946219 Review.
Cited by
-
Anti-atherosclerotic actions of azelaic acid, an end product of linoleic acid peroxidation, in mice.Atherosclerosis. 2010 Apr;209(2):449-54. doi: 10.1016/j.atherosclerosis.2009.09.076. Epub 2009 Oct 12. Atherosclerosis. 2010. PMID: 19880116 Free PMC article.
-
Performance of a Multianalyte 'Rule-Out' Assay in Pregnant Individuals With Suspected Preeclampsia.Hypertension. 2022 Jul;79(7):1515-1524. doi: 10.1161/HYPERTENSIONAHA.122.19038. Epub 2022 May 12. Hypertension. 2022. PMID: 35545947 Free PMC article.
-
Maternal plasma soluble TRAIL is decreased in preeclampsia.J Matern Fetal Neonatal Med. 2014 Feb;27(3):217-27. doi: 10.3109/14767058.2013.806906. Epub 2013 Aug 13. J Matern Fetal Neonatal Med. 2014. PMID: 23688319 Free PMC article.
-
A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia.Am J Obstet Gynecol. 2021 Dec;225(6):666.e1-666.e15. doi: 10.1016/j.ajog.2021.05.018. Epub 2021 May 24. Am J Obstet Gynecol. 2021. PMID: 34033812 Free PMC article. Clinical Trial.
-
Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk.Clin Cardiol. 2012 Mar;35(3):160-5. doi: 10.1002/clc.21965. Clin Cardiol. 2012. PMID: 22389120 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources